Marlio Charles Mosseri, 10% Owner at Nuvectis Pharma, Inc. (NVCT), bought 13,632 shares at $14.40 ($197K) on 2023-07-20, disclosed to the SEC on 2023-07-24.
Open-market purchase of $197k NVCT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.40 | 5,394 | $78K | 39.4% |
| 2 | $14.40 | 5,394 | $78K | 39.4% |
| 3 | $14.61 | 2,844 | $42K | 21.1% |
| Total | $14.44 avg | 13,632 | $197K | 100% |
| Filing → |
| NVCT | BUY | 2025-06-24 | $45K | — | Filing → |
| NVCT | BUY | 2025-06-20 | $495K | — | Filing → |
| NVCT | BUY | 2025-05-13 | $343K | — | Filing → |